Phase III, randomized, double-blind, placebo-controlled evaluation of pregabalin for alleviating hot flashes, N07C1

Journal of Clinical Oncology

Volumn 28, Issue 4, 2010, Pages 641-647

  Loprinzi, Charles L ^a   Qin, Rui ^a   Baclueva, Ernie P ^a   Flynn, Kathleen A ^a   Rowland Jr , Kendrith M ^a   Graham, David L ^a   Erwin, Nancy K ^a   Dakhil, Shaker R ^a   Jurgens, Donald J ^a   Burger, Kelli N ^a  

^a MAYO CLINIC ROCHESTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; PREGABALIN; 4 AMINOBUTYRIC ACID; ANTICONVULSIVE AGENT; DRUG DERIVATIVE;

ADULT; ARTICLE; BLURRED VISION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COORDINATION DISORDER; DIPLOPIA; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HOT FLUSH; HUMAN; MAJOR CLINICAL STUDY; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SIDE EFFECT; SOMNOLENCE; WEIGHT GAIN; ADOLESCENT; FOLLOW UP; MAXIMUM TOLERATED DOSE; MIDDLE AGED; PATHOLOGY; POSTMENOPAUSE; PROGNOSIS; QUALITY OF LIFE; SURVIVAL RATE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTICONVULSANTS; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; GAMMA-AMINOBUTYRIC ACID; HOT FLASHES; HUMANS; MAXIMUM TOLERATED DOSE; MIDDLE AGED; PLACEBOS; POSTMENOPAUSE; PROGNOSIS; QUALITY OF LIFE; SURVIVAL RATE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77449122836     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2009.24.5647     Document Type: Article

References (38)

1. McKinlay SM, Jefferys M: The menopausal syndrome. Br J Prev Soc Med 28:108-115, 1974
2. Loprinzi CL, Sloan J, Stearns V, et al: Newer antidepressants and gabapentin for hot flashes: An individual patient pooled analysis. J Clin Oncol 27: 2831-2837, 2009
3. Loprinzi CL, Kugler JW, Sloan JA, et al: Venlafaxine in management of hot flashes in survivors of breast cancer: A randomised controlled trial. Lancet 356:2059-2063, 2000
4. Speroff L, Gass M, Constantine G, et al: Efficacy and tolerability of desvenlafaxine succinate treatment for menopausal vasomotor symptoms: A randomized controlled trial. Obstet Gynecol 111:77-87, 2008
5. Loprinzi CL, Sloan JA, Perez EA, et al: Phase III evaluation of fluoxetine for treatment of hot flashes. J Clin Oncol 20:1578-1583, 2002
6. Barton DL, LaVasseur B, Sloan JA, et al: A phase III trial evaluating three doses of citalopram for hot flashes: NCCTG trial N05C9. J Clin Oncol 26:511s, 2008 (suppl; abstr 9538)
7. Gordon PR, Kerwin JP, Boesen KG, et al: Sertraline to treat hot flashes: A randomized controlled, double-blind, crossover trial in a general population. Menopause 13:568-575, 2006
8. Grady D, Cohen B, Tice J, et al: Ineffectiveness of sertraline for treatment of menopausal hot flushes: A randomized controlled trial. Obstet Gynecol 109:823-830, 2007 (Pubitemid 46559068)
9. Kimmick GG, Lovato J, McQuellon R, et al: Randomized, double-blind, placebo-controlled, crossover study of sertraline (Zoloft) for the treatment of hot flashes in women with early stage breast cancer taking tamoxifen. Breast J 12:114-122, 2006
10. Stearns V, Beebe KL, Iyengar M, et al: Paroxetine controlled release in the treatment of menopausal hot flashes: A randomized controlled trial. JAMA 289:2827-2834, 2003 (Pubitemid 37430118)
11. Stearns V, Slack R, Greep N, et al: Paroxetine is an effective treatment for hot flashes: Results from a prospective randomized clinical trial. J Clin Oncol 23:6919-6930, 2005
12. Guttuso TJ Jr: Gabapentin's effects on hot flashes and hypothermia. Neurology 54:2161-2163, 2000
13. Loprinzi C, Barton DL, Sloan JA, et al: Pilot evaluation of gabapentin for treating hot flashes. Mayo Clin Proc 77:1159-1163, 2002 (Pubitemid 35266363)
14. Thummala AR, Griggs J, Rosenblatt J, et al: Pilot study using gabapentin for tamoxifen-induced hot flashes in women with breast cancer. Proc Am Soc Clin Oncol 21:362a, 2002 (suppl; abstr 1445)
15. Guttuso T Jr, Kurlan R, McDermott MP, et al: Gabapentin's effects on hot flashes in postmenopausal women: A randomized controlled trial. Obstet Gynecol 101:337-345, 2003 (Pubitemid 36170136)
16. Pandya KJ, Morrow GR, Roscoe JA, et al: Gabapentin for hot flashes in 420 women with breast cancer: A randomised double-blind placebocontrolled trial. Lancet 366:818-824, 2005
17. Reddy SY, Warner H, Guttuso T Jr, et al: Gabapentin, estrogen, and placebo for treating hot flushes: A randomized controlled trial. Obstet Gynecol 108:41-48, 2006 (Pubitemid 44336843)
18. Butt DA, Lock M, Lewis JE, et al: Gabapentin for the treatment of menopausal hot flashes: A randomized controlled trial. Menopause 15:310-318, 2008 (Pubitemid 351354993)
19. Presant CA, Kelly C: Palliation of vasomotor instability (hot flashes) using pregabalin. Community Oncol 4:83-84, 2007
20. Therneau TM: How many stratification factors are "too many" to use in a randomization plan? Control Clin Trials 14:98-108, 1993
21. Sloan JA, Loprinzi CL, Novotny PJ, et al: Methodologic lessons learned from hot flash studies. J Clin Oncol 19:4280-4290, 2001 (Pubitemid 33096775)
22. Curran SL, Andrykowski MA, Studts JL: Short form of the profile of mood states (POMS-SF): Psychometric information. Psychol Assess 7:80-83, 1995
23. Carpenter JS: The hot flash related daily interference scale: A tool for assessing the impact of hot flashes on quality of life following breast cancer. J Pain Symptom Manage 22:979-989, 2001
24. Carpenter JS, Andrykowski MA: Menopausal symptoms in breast cancer survivors. Oncol Nurs Forum 26:1311-1317, 1999
25. Carpenter JS, Monahan PO, Azzouz F: Accuracy of subjective hot flush reports compared with continuous sternal skin conductance monitoring. Obstet Gynecol 104:1322-1326, 2004
26. Freedman RR: Laboratory and ambulatory monitoring of menopausal hot flashes. Psychophysiology 26:573-579, 1989
27. Otte JL, Flockhart D, Hayes D, et al: Comparison of subjective and objective hot flash measures over time among breast cancer survivors initiating aromatase inhibitor therapy. Menopause 16:653-659, 2009
28. Loprinzi CL, Barton DL, Sloan JA: Whose opinion counts? J Clin Oncol 24:5183-5185, 2006
29. Loprinzi CL, Barton DL: On hot flash mechanism, measurement, and treatment. Menopause 16:621-623, 2009
30. Loprinzi CL, Barton DL: Gadgets for measuring hot flashes: Have they become the gold standard? J Support Oncol 27:136-137, 2009
31. Goldberg RM, Loprinzi CL, O'Fallon JR, et al: Transdermal clonidine for ameliorating tamoxifeninduced hot flashes. J Clin Oncol 12:155-158, 1994 (Pubitemid 24020635)
32. Loprinzi CL, Michalak JC, Quella SK, et al: Megestrol acetate for the prevention of hot flashes. N Engl J Med 331:347-352, 1994
33. Loprinzi CL, Levitt R, Sloan JA, et al: Medroxyprogesterone acetate (MPA) versus venlafaxine for hot flashes: A North Central Cancer Treatment Group Trial. J Clin Oncol 23:732s, 2005 (suppl; abstr 8014)
34. Barton DL, Loprinzi CL, Quella SK, et al: Prospective evaluation of vitamin E for hot flashes in breast cancer survivors. J Clin Oncol 16:495-500, 1998 (Pubitemid 28135591)
35. Pockaj BA, Gallagher JG, Loprinzi CL, et al: Phase III double-blind, randomized, placebocontrolled crossover trial of black cohosh in the management of hot flashes: NCCTG Trial N01CC1. J Clin Oncol 24:2836-2841, 2006
36. Loprinzi CL, Levitt R, Barton D, et al: Phase III comparison of depomedroxyprogesterone acetate to venlafaxine for managing hot flashes: North Central Cancer Treatment Group Trial N99C7. J Clin Oncol 24:1409-1414, 2006 (Pubitemid 46622006)
37. Jones JM, Loprinzi CL, Qin R, et al: Hot flash placebo responses: Related to baseline hot flash frequency? J Clin Oncol 27:515s, 2009 (suppl; abstr 9628)
38. Loprinzi CL, Dueck AC, Khoyratty BS, et al: A phase III randomized, double-blind, placebocontrolled trial of gabapentin in the management of hot flashes in men (N00CB). Ann Oncol 20:542-549, 2009